Quantcast

Latest Mitral regurgitation Stories

2011-07-20 09:30:00

STOUGHTON, Mass., July 20, 2011 /PRNewswire/ -- STD Med, Inc., a worldwide manufacturer and innovator of medical devices located in Stoughton, Massachusetts, is pleased to announce that one of its internally incubated medical device technologies, Spirus Medical, Inc., has been successfully acquired by Olympus Corporation. Spirus Medical, with its proprietary "rotate to advance technology" for diagnosis and treatment of gastrointestinal (GI) disorders, is the second exit for the medical...

2011-06-29 07:00:06

(Ivanhoe Newswire) "“ Individuals with diastolic dysfunction (impaired relaxation of the heart's ventricle after contraction) appear to have increased risk of death, regardless of whether their systolic function (contraction of the ventricle) is normal or they have other cardiovascular impairments, according to this study. During each heartbeat, the heart contracts (pumping blood out, a phase called systole) and then relaxes (allowing the heart chambers to refill with blood, a phase...

2011-06-24 23:06:56

 An innovative approach for implanting a new aortic heart valve without open-heart surgery is being offered at Rush University Medical Center to patients with severe aortic stenosis who are at high-risk or not suitable candidates for open heart valve replacement surgery. "This breakthrough technology could save the lives of thousands of patients with heart valve disease who have no other therapeutic options," says Dr. Ziyad Hijazi, director of the Rush Center for Congenital and...

2011-05-04 05:00:00

KIRKLAND, Wash., May 4, 2011 /PRNewswire/ -- Cardiac Dimensions®, Inc. announced today the initiation of two new clinical studies using the CARILLON® Mitral Contour System(TM), an investigational device for percutaneous treatment of Functional Mitral Regurgitation (FMR). The CARILLON system is a minimally invasive device designed to repair the heart's mitral valve and reduce FMR, a disorder that affects most of the estimated 5 million people in the U.S....

2011-04-05 00:26:08

Measuring oxidative stress may help doctors predict the risk of developing atrial fibrillation, the most common heart beat irregularity. Research from Emory University School of Medicine has identified a connection between oxidative stress and enlargement of the heart's left atrium, which leads to atrial fibrillation. The data is being presented on Monday, April 4, by Emory cardiology researcher Nima Ghasemzadeh, MD, at the American College of Cardiology meeting in New Orleans. Working with...

2011-04-04 08:00:00

NorthShore University HealthSystem's Ted Feldman, MD, Presents Late Breaking Data at American College of Cardiology Conference EMBARGOED FOR RELEASE UNTIL 8 AM, CDT, APRIL 4, 2011 EVANSTON, Ill., April 4, 2011 /PRNewswire-USNewswire/ -- NorthShore University HealthSystem (NorthShore) interventional cardiologist, Ted Feldman, MD, presented positive results from the EVEREST II trial (Endovascular Valve Edge-to-Edge REpair STudy), that were concurrently published in The New England Journal...

2011-04-04 08:00:00

NEW ORLEANS, April 4, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced data from its EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) study showing that patients with significant mitral regurgitation (MR) treated with the company's investigational percutaneous catheter-based MitraClip® system continue to demonstrate the clinical benefits of initial treatment shown at one year out to two years, including improvements in heart function and reductions in...

2011-04-01 00:14:17

NYU Langone Medical Center surgeons are performing minimally invasive heart surgery techniques on patients in their 80s and 90s. Outcomes are strong, going against the assumption that elderly patients who have heart surgery are destined to a steady decline. New York, NY (Vocus/PRWEB) March 31, 2011 NYU Langone Medical Center has performed minimally invasive heart surgery for over 15 years. In that time there has been an increase in elderly patients. Now 5% of the surgeries are performed on...

2011-03-30 08:00:00

ABBOTT PARK, Ill., March 30, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the launch of the company's catheter-based MitraClip® system for the treatment of mitral regurgitation (MR) in Australia. The MitraClip device, which has received Therapeutic Goods Administration (TGA) approval, offers a new treatment option for patients suffering from MR, a debilitating heart valve condition. Chronic, severe MR is often associated with heart failure and can result in...

2011-01-18 06:45:00

Cardiac Surgery Market to Reach Over $4.4 Billion by 2017 VANCOUVER, Jan. 18 /PRNewswire/ - According to a new report by iData Research (www.idataresearch.net), the leading global authority in medical device and pharmaceutical market research, percutaneous aortic valve replacement (PAVR) and percutaneous mitral valve repair (PMVR) devices are expected to enter the U.S. market in 2011 and grow to almost $1.3 billion by 2017. Adoption of these devices for treating mitral regurgitation,...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.